Jonathan Jackson, U.S. Representative

Jonathan Jackson

DemocratIL01houseFiled Jul 14, 2025
11 total filings on record
Trades
2
Tickers
2
Max Value
$15K-$50K
Flags
4 Found

Tickers in This Filing

Trade Performance Intelligence

Score: 8/10
Trades Tracked
0/2
Profitable
N/A
Avg Change
N/A
Days Since
281 days

Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.

Stock Price at Trade vs. Today

Real market data showing how each stock moved since the congress member traded it.

Suspicious Timing Detected

4 flags
1.

Rep. Jackson bought $15,001 - $50,000 in $IBM on 2025-06-03, 66 days before IBM secured a $27.6M Department of Homeland Security contract.

2.

Rep. Jackson bought $15,001 - $50,000 in $IBM on 2025-06-03, 120 days before Optum Public Sector Solutions, a UnitedHealth Group subsidiary, secured a $1.1 billion Department of Veterans Affairs contract, which could be relevant to IBM's government contracting sector.

3.

Rep. Jackson bought $15,001 - $50,000 in $IBM on 2025-06-03, 13 days after HR67, the Modernizing Retrospective Regulatory Review bill, was introduced, which mandates federal agencies to adopt AI and data management.

4.

Rep. Jackson bought $15,001 - $50,000 in $IBM on 2025-06-03, 1 day before HR3702, the Extreme Heat Economic Study Act of 2025, was introduced, which mandates an economic impact study on extreme heat.

These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.

Share This Filing

All Transactions

BUY$15K-$50K
$IBMInternational Business Machines Corporation Common Stock
Jun 3, 2025 \u2022 joint
SELL$15K-$50K
$LLYEli Lilly and Company Common Stock
Jun 3, 2025 \u2022 joint

Connected Legislative Activity

9 signals

These bills and contracts share tickers or sectors with this filing's trades.

BillS1973bullish

Treat and Reduce Obesity Act of 2025

The Treat and Reduce Obesity Act of 2025 (S.1973) is in early legislative stages, aiming to expand Medicare coverage for obesity treatments, including GLP-1 agonists and intensive behavioral therapy. This bill, if enacted, would significantly increase the total addressable market for pharmaceutical companies producing obesity drugs and manufacturers of related medical devices. Companies like Eli Lilly and Company ($LLY) and Novo Nordisk A/S ($NVO) are positioned to benefit from this potential market expansion.

4/10
Jun 5, 2025
$LLY$NVO$PFE$AMGN$JNJ$ABT
BillHR3702neutral

Extreme Heat Economic Study Act of 2025

The Extreme Heat Economic Study Act of 2025 (HR3702) has been introduced in the House, mandating an economic impact study on extreme heat. While not directly funding, this bill establishes a policy directive that could increase future demand for climate risk data, analysis, and reporting services, benefiting consulting, technology, and insurance firms. The bill is in an early stage, referred to committee, with a companion bill in the Senate.

4/10
Jun 4, 2025
$IBM$ACN$MCO$SPGI$AON$CB
BillHR3491neutral

DeOndra Dixon INCLUDE Project Act of 2025

The DeOndra Dixon INCLUDE Project Act of 2025 (HR3491) has been introduced in the House and referred to the Committee on Energy and Commerce. This bill authorizes the NIH to establish a dedicated program for Down syndrome research, which could increase demand for genetic sequencing, diagnostic services, and pharmaceutical development. While the bill does not appropriate funds, it sets the framework for future funding opportunities.

4/10
May 19, 2025
$ILMN$TMO$DGX$PFE$LLY$BIIB
BillS1630neutral

MOMS Act

The MOMS Act (S. 1630) has been referred to committee, proposing the creation of a 'pregnancy.gov' website. This bill, if enacted, would generate new federal contract opportunities for web development and maintenance, impacting technology and healthcare sectors. No specific funding amounts are authorized in the current bill text.

3/10
May 6, 2025
$ACN$IBM
BillHR67bullish

Modernizing Retrospective Regulatory Review

HR67 mandates federal agencies to adopt AI and data management for regulatory review, creating a new procurement category for government tech solutions. This directly benefits established federal contractors providing AI and data services. The bill establishes a new market for AI-driven regulatory compliance tools.

5/10
May 21, 2025
$MSFT$GOOGL$AMZN$IBM$ORCL
BillS1956neutral

Strengthening Agency Management and Oversight of Software Assets Act

The Strengthening Agency Management and Oversight of Software Assets Act, S.1956, is in its early legislative stage, having been introduced and referred to committee. If enacted, this bill would mandate federal agencies to conduct comprehensive software assessments and develop management plans, creating a sustained demand for enterprise software and IT consulting services. However, the bill does not include specific funding allocations.

4/10
Jun 4, 2025
$MSFT$ORCL$IBM$ACN$CDW
Billneutral

INTERNATIONAL BUSINESS MACHINES CORPORATION: $27.6M Department of Homeland Security Contract

IBM has secured a $27.6M delivery order from the Department of Homeland Security for architecture engineering support, maintaining USCIS enterprise infrastructure. This contract represents a routine but significant win for IBM's government services division, reinforcing its role in federal IT modernization.

4/10
Aug 8, 2025
$IBM
Billbullish

OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract

Optum Public Sector Solutions, a subsidiary of UnitedHealth Group ($UNH), secured a $1.1 billion contract from the Department of Veterans Affairs, indicating significant revenue for its parent company in the healthcare technology sector. This award aligns with legislative efforts to enhance healthcare services for veterans and modernize federal health IT infrastructure.

7/10
Oct 1, 2025
$UNH$DXC$IBM
BillHR2936neutral

Addressing Boarding and Crowding in the Emergency Department

The ABC-ED Act of 2025 (HR2936) is in early committee stages, proposing to expand public health data modernization grants for tracking hospital bed capacity and emergency department metrics. While this could create demand for healthcare data analytics and IT services, the bill does not authorize specific funding, and its passage is uncertain. Current market data shows mixed performance for technology companies that could potentially benefit.

4/10
Apr 17, 2025
$ORCL$MSFT$GOOGL$IBM$DELL

Live Charts

$LLY● Sold
$IBM● Bought

Other Filings by Jonathan Jackson

Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.